G8628 HCPCS Level II code: Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis…

CMS terminated G8628: its last date of service was Dec 31, 2020. It stays here for looking up older claims; newer services need a current code.

Official description

G8628

Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

Short description: No surg proc w/in 30 days

HCPCS · United States

Medicare details

The indicators CMS publishes with G8628 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
Type of service
Medical care
BETOS category
Specialist - other
Added
Jan 1, 2010
Terminated after
Dec 31, 2020

Where G8628 sits

  1. 1G codesProcedures and professional services
  2. 2Terminated G8628Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code G8628 still valid?

No. CMS terminated G8628; its last date of service was Dec 31, 2020. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover G8628?

CMS lists G8628’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

G8598Aspirin or another antiplatelet therapy usedG8599Aspirin or another antiplatelet therapy not used, reason not givenG8600Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known wellG8601Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for…G8602Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well, reason not givenG8627Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol…G8629Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of…G8630Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision…G8631Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin…G8632Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start…G8633Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribedG8634Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis